1. Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2− Breast Cancer: A Systematic Review and Meta-Analysis
   Kai Hong et al, 2021, Oncology Research and Treatment CrossRef
2. The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients
   Xinhui Fu et al, 2021, Frontiers in Oncology CrossRef
3. Characteristics of PIK3CA gene mutations in Her2-low breast cancer
   I.A. Pavlenko et al, 2023, Arkhiv patologii CrossRef
4. PIK3CA mutations in breast cancer with low HER2 / neu expression
   I. A. Pavlenko et al, 2022, Advances in Molecular Oncology CrossRef